While those with milder forms of keratoconus can find occasional relief with corrective eyeglasses and contact lenses, many require surgical and therapeutic treatment. Corneal Cross-Linking combines the use of ultra-violet light and riboflavin eye drops to strengthen corneal tissue and halt the bulging of the eye’s surface.
Avedro’s Photrexa/KXL System is the only FDA-approved procedure for progressive keratoconus in the United States. Corneal Cross-Linking can significantly improve the vision of patients and reduce the need for corneal implants.
Along with the treatment of keratoconus, Corneal Cross-Linking can be used in the treatment of patients suffering from complications following LASIK or other vision correcting surgeries.